Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03818503

E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe

The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a multidisciplinary approach. This is an open ended prospective non-interventional non-therapeutic multi-cohort study.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cancer Neoplasms

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Medical University of Graz - Radio-oncology, Graz, Austria

Loading trial locations.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pathologically confirmed cancer.
  • Written informed consent for E²-RADIatE according to applicable legal and ethical requirements
  • Planned use of radiotherapy
  • Eligibility of the patient confirmed for at least one cohort confirmed
  • Patients of 12 years and older

Treatment and study plan

Primary outcomes

  1. Number of patients treated with radiotherapy enrolled in the program

    Time frame: 5 years

Secondary outcomes

  1. Disease free survival

    Time frame: 5 years

  2. Loco-regional control

    Time frame: 5 years

  3. Distant metastasis free survival

    Time frame: 5 years

  4. Overall survival

    Time frame: 5 years

  5. Incidence of adverse events related to radiotherapy

    Time frame: 5 years

Study contacts

Contact information is provided by the study sponsor or research team.

EORTC HQ

CONTACT

[email protected]

+32 2 774 1611

Sponsors and collaborators

Lead sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Network

Registry information

Acronym: E²-RADIatE

Important dates

Study start
2019
Primary completion
2026
Study completion
2026
First posted
Jan 28, 2019
Registry last updated
Mar 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.